+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Single Nucleotide Polymorphism"

From
From
RNA interference - Pipeline Insight, 2024 - Product Thumbnail Image

RNA interference - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 70 Pages
  • Global
From
From
From
From
US DTC Genetic Testing Market - Focused Insights 2023-2028 - Product Thumbnail Image

US DTC Genetic Testing Market - Focused Insights 2023-2028

  • Report
  • October 2023
  • 74 Pages
  • United States
From
From
From
From
From
U.S. Gene Editing Market - Industry Outlook & Forecast 2022-2027 - Product Thumbnail Image

U.S. Gene Editing Market - Industry Outlook & Forecast 2022-2027

  • Report
  • November 2022
  • 197 Pages
  • United States
From
Global Pharmacogenomics Market 2021-2026 - Product Thumbnail Image

Global Pharmacogenomics Market 2021-2026

  • Report
  • April 2021
  • 160 Pages
  • Global
From
Loading Indicator

Single Nucleotide Polymorphism (SNP) is a type of genetic variation that occurs when a single nucleotide in the genome sequence is altered. SNPs are the most common type of genetic variation among individuals and are used in genomics to identify genetic differences between individuals. SNP analysis is used to identify genetic markers associated with diseases, to study the genetic basis of complex traits, and to identify genetic variants associated with drug response. SNP analysis is used in a variety of applications, including personalized medicine, pharmacogenomics, and population genetics. SNP analysis is also used in the development of diagnostic tests, drug discovery, and gene therapy. SNP analysis is also used in the development of genetic tests for disease risk assessment and in the development of genetic tests for disease diagnosis. The SNP market is a rapidly growing market, driven by the increasing demand for personalized medicine and the development of new technologies for SNP analysis. Companies in the SNP market include Illumina, Thermo Fisher Scientific, BGI, and Genomics plc. Show Less Read more